Axel Grawingholt
Overview
Explore the profile of Axel Grawingholt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eriksson M, Roman M, Grawingholt A, Castells X, Nitrosi A, Pattacini P, et al.
Lancet Reg Health Eur
. 2024 Feb;
37:100798.
PMID: 38362558
Background: Image-derived artificial intelligence (AI)-based risk models for breast cancer have shown high discriminatory performances compared with clinical risk models based on family history and lifestyle factors. However, little is...
2.
Moshina N, Grawingholt A, Lang K, Mann R, Hovda T, Roth Hoff S, et al.
Insights Imaging
. 2024 Feb;
15(1):38.
PMID: 38332187
Objectives: The randomized controlled trial comparing digital breast tomosynthesis and synthetic 2D mammograms (DBT + SM) versus digital mammography (DM) (the To-Be 1 trial), 2016-2017, did not result in higher...
3.
Canelo-Aybar C, Posso M, Montero N, Sola I, Saz-Parkinson Z, Duffy S, et al.
Br J Cancer
. 2021 Nov;
126(4):673-688.
PMID: 34837076
Background: Although mammography screening is recommended in most European countries, the balance between the benefits and harms of different screening intervals is still a matter of debate. This review informed...
4.
Canelo-Aybar C, Carrera L, Beltran J, Posso M, Rigau D, Lebeau A, et al.
Cancer Med
. 2021 Mar;
10(7):2191-2204.
PMID: 33675147
Background: Diagnostic mammography projections (DxMM) have been traditionally used in the assessment of women recalled after a suspicious screening mammogram. Digital breast tomosynthesis (DBT) reduces the tissue overlap effect, thus...
5.
Canelo-Aybar C, Ferreira D, Ballesteros M, Posso M, Montero N, Sola I, et al.
J Med Screen
. 2021 Feb;
28(4):389-404.
PMID: 33632023
Objectives: Mammography screening is generally accepted in women aged 50-69, but the balance between benefits and harms remains controversial in other age groups. This study systematically reviews these effects to...
6.
Grawingholt A
Expert Rev Mol Diagn
. 2020 Dec;
20(12):1161-1162.
PMID: 33283564
No abstract available.
7.
Saz-Parkinson Z, Duffy S, Canelo-Aybar C, Grawingholt A, Quinn C, Follmann M, et al.
Ann Intern Med
. 2020 Jun;
172(12):840-841.
PMID: 32539513
No abstract available.
8.
Baldeh T, Saz-Parkinson Z, Muti P, Santesso N, Morgano G, Wiercioch W, et al.
Health Qual Life Outcomes
. 2020 Jun;
18(1):167.
PMID: 32503619
Background: During healthcare guideline development, panel members often have implicit, different definitions of health outcomes that can lead to misunderstandings about how important these outcomes are and how to balance...
9.
Schunemann H, Alonso-Coello P, Grawingholt A, Quinn C, Follmann M, Langendam M, et al.
Ann Intern Med
. 2020 Jan;
172(1):72-73.
PMID: 31905388
No abstract available.
10.
Schunemann H, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi P, et al.
Ann Intern Med
. 2019 Nov;
172(1):46-56.
PMID: 31766052
Description: The European Commission Initiative for Breast Cancer Screening and Diagnosis guidelines (European Breast Guidelines) are coordinated by the European Commission's Joint Research Centre. The target audience for the guidelines...